Effect of Sitagliptin in Impaired Glucose Tolerance

Summary

The purpose of this study is to examine the safety and efficacy of sitagliptin 100 mg every day (q.d.) in improving hyperglycemia and endothelial dysfunction in subjects with impaired glucose tolerance.

Timeline

Start

2009-12

Primary completion

2011-06

Completion

—

Drugs

Indications